Electroencephalogram analysis and neuroprotective profile of the N-acetylated-α-linked acidic dipeptidase inhibitor, GPI5232, in normal and brain-injured rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 299, Issue 1, 2001, Pages 48-57

  Williams, A J ^a   Lu, X M ^b   Slusher, B ^b   Tortella, F C ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b GUILFORD PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

[2 [(PENTAFLUOROPHENYLMETHYL)HYDROXYPHOSPHINYL]METHYL]PENTANEDIOIC ACID; DIPEPTIDASE; ENZYME INHIBITOR; GPI 5232; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; DOSE RESPONSE; ELECTROENCEPHALOGRAM; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; PARIETAL LOBE; PRIORITY JOURNAL; RAT; SEIZURE; SPECTROSCOPY; TEMPORAL LOBE;

ANIMALS; BEHAVIOR, ANIMAL; CARBOXYPEPTIDASES; CEREBRAL INFARCTION; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROENCEPHALOGRAPHY; GLUTAMATE CARBOXYPEPTIDASE II; GLUTARATES; MALE; MIDDLE CEREBRAL ARTERY; NEUROPROTECTIVE AGENTS; PROTEASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; SEIZURES; TIME FACTORS;

EID: 0034807624     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Predictive factors of early seizures after acute cerebrovascular disease
2. Therapy of seizures associated with stroke
3. Evaluation of 2,3,5-triphenyt tetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats
4. Dextromethorphan protects against cerebral injury following transient, but not permanent, focal ischemia in rats
5. N-Acetylaspartylglutamate selectively inhibits neuronal responses to NMDA in vitro
6. Delayed treatment with AM-36, a novel neuroprotective agent, reduces neuronal damage after endothelin-1-induced middle cerebral artery occlusion in conscious rats
7. Micromolar L-glutamate induces extensive apoptosis in a apoptotic-necrotic continuum of insult-dependent, excitotoxic injury in cultured cortical neurons
8. Acute improvement in the histological outcome by MK-801 following focal cerebral ischemia and reperfusion in the cat, independent of blood flow changes
9. Mechanisms of cell death in ischemia
10. The contribution of reoxygenation to ischemic brain damage
11. YM90K, an AMPA receptor antagonist, protects against ischemic damage caused by permanent and transient middle cerebral artery occlusion in rats
12. Emerging treatments for stroke in humans
13. Epilepsy after stroke
14. Blood-brain disruption and exacerbation of ischemic brain edema after restoration of blood flow in experimental focal cerebral ischemia
15. Excitatory amino acids as the final common pathway for neurologic disorders
16. Ischemic cell death in brain neurons
17. Quantitative EEG spectral analysis and topographic EEG mapping applied in a rat model of middle cerebral artery occlusion
18. Short therapeutic window for MK801 in transient focal cerebral ischemia in normotensive rats
19. Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: A perspective on the contributions of apoptosis and necrosis
20. Seizures decrease regional enzymatic hydrolysis of N-acetyl-aspartylglutamate in rat brain
21. Neuroprotection for acute stroke: Making clinical trials work
22. Clinical experience with excitatory amino acid antagonist drugs
23. Excitotoxins in neuronal apoptosis and necrosis
24. Correlation of triphenyl tetrazolium chloride perfusian staining with conventional neurohistology in the detection of early brain ischemia
25. The proteasome inhibitor, PS519, reduces infarction in a rat model of cerebral ischemia
26. Type and extent of hemispheric brain infarctions and clinical outcome in early and delayed middle cerebral artery recanalization
27. Rat brain N-acetylated alpha-linked acidic dipeptidase activity: Purification and immunologic characterization
28. Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces isehemic brain injury
29. Neuroprotection (focal ischemia) and neurotoxicity (electroencephalographic) studies in rats with AHN649, a 3-amino analog of dextromethorphan and low affinity NMDA antagonist
30. Neuroprotection produced by the NAALADase inhibitor 2-PMPA in rat cerebellar neurons
31. EEG spectral analysis of the neuroprotective kappa opioids enadotine and PD117302
32. Blockade of NAALADase: A novel neuroprotective strategy based on limiting glutamate and elevating NAAG
33. Neuroprotective efficacy and therapeutic window of the high affinity NMDA antagonist, Conantokin-G, in vitro in primary cerebellar cultures and in vivo in a rat model of transient focal brain isehemia
34. Topographic EEG mapping following experimental stroke in rats and treatment with the neuroprotective sodium channel blocker RS100642
35. N-Acetylaspartytglutamate inhibits forskolin-stimulated cyclic AMP levels via a metabotropic glutamate receptor in cultured cerebellar granule cells
36. Immediate or delayed mild hypothermia prevents focal cerebral infarction
37. Neurological impairment in rats after transient middle cerebral artery occlusion: A comparative study under various treatment paradigms
38. Postischemic (1 hour) hypothermia significantly reduces ischemic cell death damage in rats subjected to 2 hours of middle cerebral artery occlusion